A quantitative biometrological assessment of acne and hormonal evaluation in young women using a triphasic low-dose oral contraceptive containing gestodene

Objective To investigate the effect of a triphasic low-dose oral contraceptive pill containing gestodene on acne severity and hormone levels in young women over 13 menstrual cycles. Methods A total of 33 subjects aged 16-25 years with moderate facial acne were enrolled in the study. The primary effi...

Full description

Saved in:
Bibliographic Details
Published in:The European journal of contraception & reproductive health care 2000, Vol.5 (4), p.275-286
Main Authors: Piérard-Franchimont, C., Gaspard, U., Lacante, P., Rhoa, M., Slachmuylders, P., Piérard, G. E.
Format: Article
Language:English
Subjects:
Acne
Acne Vulgaris - drug therapy
Adolescent
Adult
Androgens
Androgens - blood
Biometrology
Contraceptives, Oral, Synthetic - pharmacology
Contraceptives, Oral, Synthetic - therapeutic use
Estradiol - blood
Female
Hormones - blood
Humans
Norpregnenes - pharmacology
Norpregnenes - therapeutic use
Oral contraception
Progesterone - blood
Progesterone Congeners - pharmacology
Progesterone Congeners - therapeutic use
Severity of Illness Index
Sex Hormone-Binding Globulin - metabolism
Treatment Outcome
Triphasic gestodene
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To investigate the effect of a triphasic low-dose oral contraceptive pill containing gestodene on acne severity and hormone levels in young women over 13 menstrual cycles. Methods A total of 33 subjects aged 16-25 years with moderate facial acne were enrolled in the study. The primary efficacy end-points used in the clinical assessment of acne were the overall severity and number of lesions, sebum secretion and superficial follicular biopsy. Both physicians and patients evaluated acne status. Blood levels of sex hormone binding globulin (SHBG), estradiol, progesterone and androgens were monitored. Results By cycle 13, the total lesion count had been reduced by 80%. Physicians and patients assessed acne status in 90% and 95% of cases, respectively, as better or much better (p < 0.001). At the end of the study, SHBG levels had increased by 229% and total and free testosterone levels had decreased by 41% and 70%, respectively. Conclusion An oral contraceptive containing triphasic gestodene has a beneficial effect on the severity of acne, decreases major circulating androgen levels and is well tolerated.
ISSN:1362-5187
1473-0782
DOI:10.1080/13625180008500405